| Application no. and date | 01906021.9 (espacenet) (Federated) (European Patent Register), 20010226 | | Patent/reg. no. and date | DK/EP 1278735, 20100630 | | Publication date | 20030129 | | Priority no. and date | GB 0004887, 20000301 | | EP pub. no. and date |
EP 1278735 20030129 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | AST Z70678-X | | Inventor | PEASE, Elizabeth, Janet, Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
WILLIAMS, Emma, Jane, Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
PEARSON, Stuart, Eric, Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
BRADBURY, Robert, Hugh, Alderley Park
Macclesfield, Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | C07D 239/48 (2006.01) , C07D 403/12 (2006.01) | | Title | 2,4-di(hetero-)arylamino(-oxy)-5-substituerede pyrimidiner som antineoplastiske midler | | Int. application no. | GB2001000829 | | Int. publication no. | WO2001064656 | | Related patent (certificate) | CA 2021 00003 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
